The rationale behind introducing CDX2 as a marker specific for CRC characterization was its potentially predictive role in CRC based on previously reported correlation between CDX2 expression and CRC grade, stage and metastasis [21, 22]. Here, CDX2 is linked to colorectal carcinoma.